BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8900893)

  • 1. [AgNOR analysis of astrocytoma in childhood].
    Haberland C; Martin H; Guski H; Hufnagl P; Vogel S
    Zentralbl Neurochir; 1996; 57(1):5-11. PubMed ID: 8900893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AgNOR- and PCNA-studies in astrocytomas of the optic nerve.
    Patt S; Giraldo M; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location of nucleolar organizer regions (AgNORs) in the nuclei of astrocytic tumors.
    Pedal WP; Warzok RW; Hufnagl P; Roth K
    Clin Neuropathol; 1995; 14(1):55-61. PubMed ID: 7729083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argyrophilic nucleolar organizer region (AgNOR) counting in astrocytic gliomas: prognostic value.
    Ferreres JC; Figols J; Val-Bernal JF; Cardesa A; Cruz Sánchez FF
    Histol Histopathol; 1996 Jan; 11(1):35-9. PubMed ID: 8720446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.
    Yu CC; Fletcher CD; Newman PL; Goodlad JR; Burton JC; Levison DA
    J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
    Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
    Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [AgNOR in neurooncology].
    Martin H; Gottschalk J; Hufnagl P; Beil M
    Acta Histochem Suppl; 1992; 42():179-84. PubMed ID: 1584963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Importance of AgNOR analysis in malignant tumors].
    Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):15-22. PubMed ID: 8204559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measuring of AgNORs using image analysis.
    Hufnagl P; Guski H; Schulz HJ
    Zentralbl Pathol; 1994 Mar; 140(1):31-5. PubMed ID: 7515670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleolar organizer regions (AgNORs) in astrocytic tumors.
    Pedal WP; Warzok RW; Hufnagl P; Roth K
    Zentralbl Pathol; 1994 Mar; 140(1):89-94. PubMed ID: 7515679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nucleolus organizer regions in pathomorphologic tumor diagnosis].
    Rüschoff J
    Veroff Pathol; 1992; 139():1-144. PubMed ID: 1413987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor proliferative fraction in infiltrating duct carcinoma.
    Kesari AL; Chellam VG; Nair PP; Madhavan J; Nair P; Nair MK; Pillai MR
    Gen Diagn Pathol; 1997 Dec; 143(4):219-24. PubMed ID: 9489954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of AgNORs in breast cancer].
    Aubele M; Auer G; Jütting U
    Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of proliferative activity of ovarian carcinoma as revealed by PCNA and AgNOR analyses.
    Ghazizadeh M; Sasaki Y; Araki T; Konishi H; Aihara K
    Am J Clin Pathol; 1997 Apr; 107(4):451-8. PubMed ID: 9124214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
    Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
    Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved system for quantifying AgNOR and PCNA in canine tumors.
    Hung LC; Pong VF; Cheng CR; Wong FI; Chu RM
    Anticancer Res; 2000; 20(5A):3273-80. PubMed ID: 11062753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AgNOR pattern and PCNA analysis in fine needle biopsies of liver cell carcinoma.
    Valenca JT; Escanhoel CA; Metze K
    Neoplasma; 2001; 48(5):370-3. PubMed ID: 11845981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
    Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
    Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolar organizer regions (AgNORs) in primary and recurrent gliomas. A retrospective study.
    Engel U; Plate K; Jänisch W; Mennel HD
    Zentralbl Pathol; 1994 Mar; 140(1):73-81. PubMed ID: 7515677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.